Obstetric core conditions 3 Flashcards
Risks of prematurity
- Increased mortality depends on the gestation
- Respiratory distress syndrome
- Intraventricular haemorrhage
- Necrotizing enterocolitis
- Chronic lung disease, hypothermia, feeding problems, infection, jaundice
- Retinopathy of prematurity: important cause of visual impairment in babies born before 32 weeks gestation
- Hearing problems
Complications of PPROM
- Fetal: prematurity, infection, pulmonary hypoplasia
- Maternal: chorioamnionitis
2% of pregnancies but 40% of preterm deliveries
Investigation of PPROM
A sterile speculum examination should be performed (to look for pooling of amniotic fluid in the posterior vaginal vault) but digital examination should be avoided due to the risk of infection. Ultrasound may also be useful to show oligohydramnios
Management of PPROM
- Admission
- Regular observations to ensure chorioamnionitis is not developing
- Oral erythromycin should be given for 10 days
- Antenatal corticosteroids should be administered to reduce the risk of respiratory distress syndrome
- Delivery should be considered at 34 weeks of gestation - there is a trade-off between increased risk of maternal chorioamnionitis with a decreased risk of respiratory distress syndrome as the pregnancy progresses
Categories of preterm baby
Preterm baby: birth prior to 37 weeks
- Extremely preterm <28 weeks
- Very preterm= 28 – 31+6 weeks
- Moderate to late preterm= 32 – 36+6 weeks
Risk factors for a preterm baby
- Multiple pregnancy
- Cone biopsy/LLETZ
- Obstetric cholestasis
- Pre-eclampsia
- Diabetes
- Antiphospholipid syndrome
- Uterine abnormality
Planned preterm babys
In 25% of preterm births, the delivery is planned (IOL / CS) due to maternal or fetal complications, for example pre-eclampsia, fetal growth restriction, chorioamnionitis, or PPROM (preterm premature rupture of membranes).
Preterm delivery prophylaxis
- If a women has had a previous preterm delivery/ mid-trimester loss, cervical loss shortening- vaginal progesterone or cervical cerclage
- At risk of preterm delivery- corticosteroids aid fetal lung maturity (between 24-34+6 weeks if vaginal delivery, up to 38+6 in CS). Other pharmacological agents include magnesium sulfate for neuroprotection and nifedipine for tocolysis.
Medication in P-PROM
Offer women with P-PROM oral erythromycin 250 mg 4 times a day for a maximum of 10 days or until the woman is in established labour (whichever is sooner)
Diagnosis of P-PROM
- Speculum examination shows pooling of amniotic fluid in the vagina
- If in doubt: IGFBP-1 and PAMG-1 in the vaginal fluid prove P-PROM
Preterm labour with intact membranes
- Involves regular painful contractions and cervical dilation without rupture of the amniotic sac
- Less than 30 weeks gestation, clinical assessment alone is enough to offer management of preterm labour.
- More than 30 weeks gestation, a transvaginal ultrasound can be used to assess the cervical length. When the cervical length on ultrasound is less than 15mm, management of preterm labour can be offered. A cervical length of more than 15mm indicates preterm labour is unlikely.
Fetal Fibronectin
A result of less than 50 ng/ml is considered negative, and indicates that preterm labour is unlikely.
Management of preterm labour
- Fetal monitoring (CTG or intermittent auscultation)
- Tocolysis with nifedipine: nifedipine is a calcium channel blocker that suppresses labour
- Maternal corticosteroids: can be offered before 35 weeks gestation
- IV magnesium sulphate: can be given before 34 weeks gestation and helps protect the baby’s brain
- Delayed cord clamping or cord milking: can increase the circulating blood volume and haemoglobin in the baby at birth
Reduced fetal movement
Movement first perceived between 18-20 weeks of gestation. Reduced or absent movement could signal death. Fetal movements are usually absent during fetal ‘sleep’ cycles; these occur throughout the day and usually last 20-40 minutes, rarely exceeding 90 minutes in a healthy fetus.
Reduced fetal movement- examination
- SFH- to assess fetal size
- Auscultation of the fetal heart using a handheld doppler
- CTG- if the women is over 28 weeks gestational age
- Ultrasound- if there is reduced movement even after normal CTG
- If no fetal movement has been felt by 24 weeks gestation- referral to a specialist fetal medicine centre to investigate for neuromuscular conditions
Risk factors for reduced fetal movements
- Posture- being more prominent during lying down and less when sitting and standing
- Distraction
- Placental position- Patient with anterior placentas prior to 28 weeks gestation may have lesser awareness of fetal movements
- Medication- Both alcohol and sedative medications like opiates or benzodiazepines can temporarily cause reduced fetal movements
- Fetal position- Anterior fetal position means movements are less noticeable
- Body habitus- Obese patients are less likely to feel prominent fetal movements
- Amniotic fluid volume- Both oligohydramnios and polyhydramnios can cause reduction in fetal movements
- Fetal size- Up to 29% of women presenting with RFM have a SGA fetus
Definition of reduced fetal movements
Less than 10 movements within 2 hours in pregnancies past 28 weeks gestation. Usually based just on maternal perception though can be objectively assessed with a hand held Doppler or ultrasonography
Reduced fetal movement- investigations
- Initially, handheld Doppler should be used to confirm fetal heartbeat.
- If no fetal heartbeat detectable, immediate ultrasound should be offered.
- If fetal heartbeat present, CTG should be used for at least 20 minutes to monitor fetal heart rate which can assist in excluding fetal compromise.
- If concern remains, despite normal CTG, urgent (within 24 hours) ultrasound can be used.
SGA and FGR
Small for gestational age (SGA): birth weight less than the 10th centile
Fetal growth restriction (FGR): a pathological restriction of genetic growth potential. Different to SGA.
Causes for SGA fetus’s are divided into 3 categories
- Normal (constitutionally) small
- Non-placenta mediated growth restriction – structural / chromosomal anomaly, inborn errors of metabolism, fetal infections
- Placenta medicated growth restriction – cigarette smoking, severe anaemia, pre-eclampsia, diabetes, hypertension